VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,948,032 | -11.6% | 109,552 | -1.1% | 0.39% | -13.4% |
| Q2 2023 | $3,336,686 | +69.3% | 110,817 | +81.9% | 0.45% | +45.0% |
| Q1 2023 | $1,970,780 | -39.0% | 60,921 | -54.4% | 0.31% | -48.9% |
| Q4 2022 | $3,230,762 | -10.9% | 133,686 | -11.3% | 0.61% | -8.4% |
| Q3 2022 | $3,627,000 | +250.1% | 150,724 | +298.5% | 0.67% | +244.3% |
| Q2 2022 | $1,036,000 | -0.6% | 37,824 | +39.2% | 0.19% | +24.4% |
| Q1 2022 | $1,042,000 | +2.0% | 27,176 | -14.8% | 0.16% | +9.9% |
| Q4 2021 | $1,022,000 | -3.7% | 31,897 | -11.4% | 0.14% | +1.4% |
| Q3 2021 | $1,061,000 | -95.1% | 36,009 | -94.3% | 0.14% | -91.3% |
| Q2 2021 | $21,477,000 | +83.7% | 634,057 | +76.2% | 1.61% | +6.5% |
| Q1 2021 | $11,694,000 | -31.7% | 359,812 | -24.3% | 1.52% | -43.5% |
| Q4 2020 | $17,117,000 | +19.3% | 475,209 | +30.6% | 2.68% | +5.6% |
| Q3 2020 | $14,346,000 | +28.5% | 363,790 | +21.2% | 2.54% | +11.3% |
| Q2 2020 | $11,168,000 | +102.8% | 300,233 | +42.3% | 2.28% | +65.1% |
| Q1 2020 | $5,507,000 | +123.0% | 210,991 | +150.2% | 1.38% | +94.1% |
| Q4 2019 | $2,469,000 | +445.0% | 84,313 | +396.8% | 0.71% | +321.3% |
| Q3 2019 | $453,000 | +2.7% | 16,970 | -1.7% | 0.17% | +11.9% |
| Q2 2019 | $441,000 | +1596.2% | 17,270 | +1414.9% | 0.15% | +1577.8% |
| Q1 2019 | $26,000 | -72.0% | 1,140 | -74.1% | 0.01% | -78.0% |
| Q4 2018 | $93,000 | -76.9% | 4,400 | -79.8% | 0.04% | -69.2% |
| Q3 2018 | $403,000 | +179.9% | 21,785 | +236.7% | 0.13% | +125.4% |
| Q2 2018 | $144,000 | -24.6% | 6,470 | -25.5% | 0.06% | +5.4% |
| Q1 2018 | $191,000 | +105.4% | 8,685 | +117.1% | 0.06% | +86.7% |
| Q4 2017 | $93,000 | -55.1% | 4,000 | -55.6% | 0.03% | -64.3% |
| Q3 2017 | $207,000 | +1.0% | 9,000 | 0.0% | 0.08% | -1.2% |
| Q2 2017 | $205,000 | -3.3% | 9,000 | -2.3% | 0.08% | -8.6% |
| Q1 2017 | $212,000 | -58.8% | 9,210 | -62.6% | 0.09% | -57.3% |
| Q4 2016 | $515,000 | +22.0% | 24,615 | +54.1% | 0.22% | -10.7% |
| Q3 2016 | $422,000 | -11.2% | 15,975 | 0.0% | 0.24% | -18.1% |
| Q2 2016 | $475,000 | – | 15,975 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |